Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.

Azukaitis K, Ju W, Kirchner M, Nair V, Smith M, Fang Z, Thurn-Valsassina D, Bayazit A, Niemirska A, Canpolat N, Bulut IK, Yalcinkaya F, Paripovic D, Harambat J, Cakar N, Alpay H, Lugani F, Mencarelli F, Civilibal M, Erdogan H, Gellermann J, Vidal E, Tabel Y, Gimpel C, Ertan P, Yavascan O, Melk A, Querfeld U, Wühl E, Kretzler M, Schaefer F; 4C Study; ESCAPE Trial Group.

Kidney Int. 2019 Mar 20. pii: S0085-2538(19)30184-X. doi: 10.1016/j.kint.2019.01.035. [Epub ahead of print]

PMID:
31005273
2.

[HELLP syndrome and hemolytic uremic syndrome during pregnancy: two disease entities, same causation. Case report and literature review].

Mancini A, Ardissino G, Angelini P, Giancaspro V, La Raia E, Nisi M, Proscia A, Tarantino G, Vitale O, D'elia F.

G Ital Nefrol. 2019 Apr;36(2). pii: 2019-vol2. Italian.

PMID:
30983177
3.

Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome.

Siedlecki AM, Isbel N, Vande Walle J, James Eggleston J, Cohen DJ; Global aHUS Registry.

Kidney Int Rep. 2018 Dec 3;4(3):434-446. doi: 10.1016/j.ekir.2018.11.010. eCollection 2019 Mar.

4.

Haploidentical Hematopoietic Stem Cell Transplant Complicated by Atypical Hemolytic Uremic Syndrome and Kidney Transplant From the Same Donor With No Immunosuppression but C5 Inhibition.

Ardissino G, Cresseri D, Giglio F, Onida F, Iannuzzella F, Tel F, Giussani A, Messa P, Longhi S, Vincenti D, Tedeschi S, Cugno M, Ciceri F.

Transplantation. 2019 Feb;103(2):e48-e51. doi: 10.1097/TP.0000000000002505.

PMID:
30365467
5.

Soluble Toll-Like Receptor 4 Impairs the Interaction of Shiga Toxin 2a with Human Serum Amyloid P Component.

Brigotti M, Arfilli V, Carnicelli D, Ricci F, Tazzari PL, Ardissino G, Scavia G, Morabito S, He X.

Toxins (Basel). 2018 Sep 18;10(9). pii: E379. doi: 10.3390/toxins10090379.

6.

A simple prognostic index for Shigatoxin-related hemolytic uremic syndrome at onset: data from the ItalKid-HUS network.

Ardissino G, Tel F, Testa S, Paglialonga F, Longhi S, Martelli L, Consolo S, Picicco D, Dodaro A, Daprai L, Colombo R, Arghittu M, Perrone M, Chidini G, Scalia Catenacci S, Cropanese I, Consonni D; ItalKid-HUS Network.

Eur J Pediatr. 2018 Nov;177(11):1667-1674. doi: 10.1007/s00431-018-3198-7. Epub 2018 Aug 10.

PMID:
30094644
7.

Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome.

Schaefer F, Ardissino G, Ariceta G, Fakhouri F, Scully M, Isbel N, Lommelé Å, Kupelian V, Gasteyger C, Greenbaum LA, Johnson S, Ogawa M, Licht C, Vande Walle J, Frémeaux-Bacchi V; Global aHUS Registry.

Kidney Int. 2018 Aug;94(2):408-418. doi: 10.1016/j.kint.2018.02.029. Epub 2018 Jun 19.

PMID:
29907460
8.

Serum creatinine during physiological perinatal dehydration may estimate individual nephron endowment.

Ardissino G, Tel F, Possenti I, Pavesi M, Perrone M, Forni G, Salice P, Colombo L, Ghirardello S, Castiglione B, Consonni D, Baca L, Vecchi DL, la Marca G, Mosca F.

Eur J Pediatr. 2018 Sep;177(9):1383-1388. doi: 10.1007/s00431-018-3087-0. Epub 2018 Feb 1.

PMID:
29387982
9.

An Improved Method for the Sensitive Detection of Shiga Toxin 2 in Human Serum.

He X, Ardissino G, Patfield S, Cheng LW, Silva CJ, Brigotti M.

Toxins (Basel). 2018 Jan 31;10(2). pii: E59. doi: 10.3390/toxins10020059.

10.

Management and outcomes of childhood Goodpasture's disease.

Menzi CP, Bucher BS, Bianchetti MG, Ardissino G, Simonetti GD.

Pediatr Res. 2018 Apr;83(4):813-817. doi: 10.1038/pr.2017.315. Epub 2018 Jan 10.

PMID:
29244791
11.

Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations.

Sanna-Cherchi S, Khan K, Westland R, Krithivasan P, Fievet L, Rasouly HM, Ionita-Laza I, Capone VP, Fasel DA, Kiryluk K, Kamalakaran S, Bodria M, Otto EA, Sampson MG, Gillies CE, Vega-Warner V, Vukojevic K, Pediaditakis I, Makar GS, Mitrotti A, Verbitsky M, Martino J, Liu Q, Na YJ, Goj V, Ardissino G, Gigante M, Gesualdo L, Janezcko M, Zaniew M, Mendelsohn CL, Shril S, Hildebrandt F, van Wijk JAE, Arapovic A, Saraga M, Allegri L, Izzi C, Scolari F, Tasic V, Ghiggeri GM, Latos-Bielenska A, Materna-Kiryluk A, Mane S, Goldstein DB, Lifton RP, Katsanis N, Davis EE, Gharavi AG.

Am J Hum Genet. 2017 Dec 7;101(6):1034. doi: 10.1016/j.ajhg.2017.11.003. No abstract available.

12.

Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations.

Sanna-Cherchi S, Khan K, Westland R, Krithivasan P, Fievet L, Rasouly HM, Ionita-Laza I, Capone VP, Fasel DA, Kiryluk K, Kamalakaran S, Bodria M, Otto EA, Sampson MG, Gillies CE, Vega-Warner V, Vukojevic K, Pediaditakis I, Makar GS, Mitrotti A, Verbitsky M, Martino J, Liu Q, Na YJ, Goj V, Ardissino G, Gigante M, Gesualdo L, Janezcko M, Zaniew M, Mendelsohn CL, Shril S, Hildebrandt F, van Wijk JAE, Arapovic A, Saraga M, Allegri L, Izzi C, Scolari F, Tasic V, Ghiggeri GM, Latos-Bielenska A, Materna-Kiryluk A, Mane S, Goldstein DB, Lifton RP, Katsanis N, Davis EE, Gharavi AG.

Am J Hum Genet. 2017 Nov 2;101(5):789-802. doi: 10.1016/j.ajhg.2017.09.018. Erratum in: Am J Hum Genet. 2017 Dec 7;101(6):1034.

13.

Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update.

Ardissino G, Tel F, Sgarbanti M, Cresseri D, Giussani A, Griffini S, Grovetto E, Possenti I, Perrone M, Testa S, Paglialonga F, Messa P, Cugno M.

Pediatr Nephrol. 2018 Mar;33(3):457-461. doi: 10.1007/s00467-017-3813-2. Epub 2017 Oct 18.

PMID:
29046944
14.

Late Onset Cobalamin Disorder and Hemolytic Uremic Syndrome: A Rare Cause of Nephrotic Syndrome.

Ardissino G, Perrone M, Tel F, Testa S, Morrone A, Possenti I, Tagliaferri F, Dilena R, Menni F.

Case Rep Pediatr. 2017;2017:2794060. doi: 10.1155/2017/2794060. Epub 2017 Aug 1.

15.

Comment to "Blood urea nitrogen to serum creatinine ratio is an accurate predictor of outcome in diarrhea-associated hemolytic uremic syndrome" by Keenswijk et al. Eur J Pediatr 2017; 176(3): 355-360.

Ardissino G, Tel F, Picicco D, Dodaro A, Daprai L, Consolo S, Testa S, Paglialonga F, Consonni D; ItalKid HUS Network.

Eur J Pediatr. 2018 Feb;177(2):269-270. doi: 10.1007/s00431-017-2989-6. Epub 2017 Aug 19. No abstract available.

PMID:
28823076
16.

Response.

Ardissino G, Tedeschi S, Zecca M, Berra S, Colussi G, Giglio F, Terruzzi E, Cugno M.

Biol Blood Marrow Transplant. 2017 Nov;23(11):2014-2015. doi: 10.1016/j.bbmt.2017.07.017. Epub 2017 Aug 15. No abstract available.

17.

[Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease].

Visconti L, Cernaro V, Ardissino G, Sgarbanti M, Ferrara D, Visconti G, Santoro D, Buemi M.

G Ital Nefrol. 2017 Apr;34(2):74-81. Italian.

PMID:
28682564
18.

Bioimpedance-based rather than weight-based ultrafiltration prescription for children on maintenance hemodialysis
.

Ardissino G, Belingheri M, Perrone M, Tel F, Consonni D, Testa S.

Clin Nephrol. 2018 Oct;90(4):286-290. doi: 10.5414/CN109109.

PMID:
28619128
19.

Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs.

Stefanutti C, Julius U, Watts GF, Harada-Shiba M, Cossu M, Schettler VJ, De Silvestro G, Soran H, Van Lennep JR, Pisciotta L, Klör HU, Widhalm K, Moriarty PM; MIGHTY MEDIC Multinational Society.

J Clin Lipidol. 2017 Jul - Aug;11(4):858-871.e3. doi: 10.1016/j.jacl.2017.04.114. Epub 2017 Apr 25. Review.

20.

Acquired Complement Regulatory Gene Mutations and Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy.

Ardissino G, Salardi S, Berra S, Colussi G, Cugno M, Zecca M, Giglio F, Peccatori J, Diral E, Tel F, Clivio A, Tedeschi S.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1580-1582. doi: 10.1016/j.bbmt.2017.05.013. Epub 2017 May 15.

Supplemental Content

Loading ...
Support Center